Advisory: Alert on Bellicum Pharmaceuticals' quarterly revenue withdrawn
28/11/2018 13:58
(An alert on Bellicum Pharmaceuticals' BLCM.O quarterly
revenue is wrong and has been withdrawn. The alert was
inadvertently issued from a press release by a research firm.
Bellicum Pharmaceuticals reported its third-quarter results on
Nov. 6 urn:newsml:reuters.com:*:nASB00UZD)
STORY_NUMBER: ASB00YO0
STORY_DATE: 28/11/2018
STORY_TIME: 13:30:11
((Bangalore.newsroom@thomsonreuters.com))
Recent news on Bellicum Pharmaceuticals
See all newsBrief: Bellicum Pharmaceuticals- In Connection With Dissolution And Plan Of Dissolution, On February 23, Richard A. Fair Resigned As President And Co's CEO
Brief: Bellicum Pharmaceuticals Says Board Approved Liquidation And Dissolution Of Co In Connection With Approval Of Asset Purchase Agreement
Brief: Bellicum Pharmaceuticals Initiated A 12 Stock Split On Dec 8, 2022
Brief: Bellicum Reports Third Quarter 2022 Financial Results And Provides Operational Update
Bellicum Pharmaceuticals Inc expected to post a loss of 64 cents a share - Earnings Preview